Everand Logo

Welcome to Everand!

  • STAT

    Teva reaches $85 million settlement on eve of opioid trial in Oklahoma

    On the eve of a closely watched trial, Teva agreed to pay $85 million to settle charges made by the state of Oklahoma of fueling the opioid crisis by overstating…
    by Ed Silverman May 26, 2019 2 minutes
    A Teva Pharmaceutical facility building in Neot Hovav, Israel.

    On the eve of a closely watched trial, Teva Pharmaceutical () agreed to pay $85 million to settle charges made by the state of Oklahoma of fueling the opioid crisis by overstating the benefits of its opioid painkillers and downplaying addictive risks that led doctors to

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
    A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
    STAT1 min read
    USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
    With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.
    STAT1 min read
    Opinion: STAT+: How AI Can Help Satisfy FDA’s Drug, Device Diversity Requirements
    To meet the Food and Drug Omnibus Reform Act, companies must rethink their current clinical trial strategies. Including AI and machine learning approaches can help.

    Related Books & Audiobooks